Dhaka, Bangladesh (BBN)– Standard Chartered Bank has arranged a syndicated term loan of BDT 920 million for ACME Specialized Pharmaceuticals.
The loan will help finance the expansion of ACME’s production to introduce new products in response to growing demand in the market.
The agreement was signed by the pharmaceutical and Standard Chartered (the lead arranger) and other financial institutions.
Participants include AB Bank, Bank Alfalah, Commercial Bank of Ceylon, Dhaka Bank, Eastern Bank, Saudi-Bangladesh Industrial and Agricultural Investment Company, Southeast Bank, and Standard Bank.
Mizanur Rahman Sinha, managing director of the pharmaceuticals company, thanked the financial institutions for coming forward and financing the expansion of the business.
“Standard Chartered is delighted to be the mandated lead arranger and agent for ACME in this transaction,” said Abrar A Anwar, managing director and head of origination and client coverage of Standard Chartered.
The signing ceremony was attended by the chief executive officers and managing directors of all participating banks, as well as several important personalities of the Bangladesh financial sector.
Standard Chartered Bank Bangladesh has been the pioneer in introducing innovative financial solutions for its clients, and has played a vital role in developing the structured financing segment. 
The UK-based bank has arranged several local and foreign currency syndicated loan facilities for the power, telecommunication, infrastructure, food & beverage, textile, service and other key sectors.
 
BBN/SSR/AD-08May12-8:40 am (BST)